Production of Covid-19 vaccine could top 16 billion doses, but delivery is still a challenge

Manufacturing limits, a nation’s health care system and intellectual property rights could all affect which countries receive vaccines and how quickly. Of 16 billion doses manufacturers expect to make next year, over 8 billion have already been committed to countries